INTRODUCTION
Hyaline cartilage provides a low-friction gliding surface, with increased compressive strength and it is known to be wear-resistant under normal circumstances. It consists of chondrocytes and a dense extracellular matrix composed primarily of water, collagen, and proteoglycan. Articular cartilage is a highly-specialized tissue with poor regenerative capacities, because of its low metabolic activity. In this way, the balance between anabolism and catabolism of the matrix is crucial for this tissue homeostasis (BHOSALE & RICHARDSON, 2008; PEARLE et al., 2005) .
Chondrocyte metabolism is responsible for the maintenance of a stable and abundant extracellular matrix. Unfortunately, at some point the biosynthetic anabolic activity is unable to keep the pace with the degradative catabolic activity, and degeneration of the tissue results, leading to the occurrence of diseases such as osteoarthritis (OA) (SANDELL & AIGNER, 2001) .
The wear and tear is the most commonly quoted theory for the pathogenesis of OA in horses, supported by its presence in younger horses used for athletic activity (KIDD et al., 2001) . GALLIO et al. (2014) reported a high incidence of articular lesions in horses under three years old, its occurrence in young ages aggravates the consequences of the disease, once OA has a detrimental effect in the equine industry because of the delayed return to athletic performance. Palma et al. In response to mechanical stress, immunomodulatory and inflammatory mediators, as some cytokines involved with the articular damage in OA, chondrocytes produce abnormal levels of reactive oxygen species (ROS) and reactive nitrogen species (HENROTIN et al., 2003) . ROS play a crucial role in regulation of a number of chondrocyte activities such as cell activation, proliferation and matrix remodeling (HENROTIN et al., 2005) . The ROS are capable of degrading many components of the joint in the presence of insufficient antioxidant defenses, and as a result, ROS have been implicated in the pathogenesis of joint disease in horses (DIMOCK et al., 2000) .
Substances that protect articular cartilage during the course of OA have been termed chondroprotective agents (VERBRUGGEN, 2006) . Among the medications available for the treatment of OA, corticosteroids are the most potent regarding its anti-inflammatory activity and have been a mainstay in the treatment of joint disease for nearly half a century (CARON, 2005) . Triamcinolone acetonide (TA) is one of the most commonly used corticosteroid, especially because of its safety and beneficial effects (CARON, 2005; WILLIAMS & BRANDT, 1985) .
Although, TA is considered safe, there is a progressive need to find other therapeutic options to retard the progression of osteoarthritis, once some studies demonstrated that TA can be harmful to joints. FUBINI et al. (2001) showed that corticosteroids could decrease chondrocyte expression of matrix proteins contributing to cartilage degeneration. SUNTIPARPLUACHA et al. (2016) assessed the cytotoxicity and oxidative stress caused by TA on chondrocytes from OA knees. The TA induced chondrotoxicity by increasing oxidative stress and altering expressions of genes involved in cell death. Exact mechanisms of chondrotoxicity are not completely understood, but could be a result of the oxidative stress caused by TA.
Platelet-rich plasma (PRP) has been extensively studied in the dentistry and nowadays is one of the most popular biological products for equine regenerative medicine. The PRP contains a mix of growth factors, cytokines derived from platelets and clotting proteins that results in anabolic effects on both cells and tissue cultures, been important in the processes of tissue repair (SMITH et al., 2014; WASTERLAIN et al., 2012 ). An advantage of using PRP is that patients can return to sports more quickly, as compared with patients treated with traditional surgical protocols (LOPEZ-VIDRIERO et al., 2010) .
Another chondroprotective drug to control OA progression is pentosan polysulphate sodium (PPS). It is known that PPS stimulates proteoglycan synthesis in vitro and suppresses cartilage degradation in animals with OA (GHOSH, 1999) . FREAN et al. (2002) also demonstrated an increase in proteoglycan synthesis occurring at chondrocytes cultures from horses treated with PPS. In veterinary medicine, PPS is used mainly for prophylaxis and /or treatment of OA despite of limited scientific evidence proving its efficacy in horses (KRAMER et al., 2014) .
Those substances are considered safe to the articular environment, once they do not interfere with the articular anatomical structure. However, the aim of this study was to investigate the oxidative profile resulting from their use on chondrocytes cultures, which can result in cell death. Also, the evaluation of oxidative parameters may be an early detection of tissue injury.
MATERIALS AND METHODS

Isolation of articular chondrocytes of horses
For this study, metacarpophalangeal joints of five adult horses with age varying between 5 to 12 years old were collected from an abattoir. Animals were considered healthy through clinical and radiographic evaluation. The limbs were sectioned at the carpometacarpal joint, cleaned and the hair removed.
Under aseptic conditions in a laminar flow chamber, the selected joints were surgically exposed and the cartilage was removed in small fragments. Chondrocytes were isolated from articular cartilage as described by CRUZ et al. (1990) with some modifications. Briefly fragments were placed in a Petri dish containing DMEM (Dulbecco Modified Eagle's Medium) culture medium supplemented with 10% fetal bovine serum (FBS), 60 U/mL penicillin, 60 μg/mL streptomycin and 2 mmol/L glutamine. Then cartilage fragments were washed three times and underwent enzymatic digestion in Falcon tubes in order to isolate the chondrocytes. For this, chondrocytes were incubated in Pronase medium for 1h30 min and, after washing three times, were incubated in Falcon tubes for approximately 18 hours in collagenase medium. Two incubations that compose the digestion process were carried out at 37 ºC in a humidified atmosphere with 95% air and 5% CO 2 .
After digestion with collagenase, cells were washed three times in culture medium to eliminate the enzyme and thus halting digestion. Cell suspension was collected into a 50 mL Falcon tube and the volume supplemented by addition of culture medium DMEM. Afterwards, it was allowed a five minutes rest to the cell suspension, so that small fragments of non-digested cartilage could be separated, and isolated from the chondrocytes suspension. Cell suspension was aspirated and transferred to a new Falcon tube. The cell suspension in the Falcon tube was then centrifuged at 200 x g for five minutes. After the third wash, the cells were suspended in culture medium supplemented with 5% (v/v) FBS.
Cell density of the suspension obtained was determined by counting cells in Neubauer's hemocytometer. Cell viability was evaluated simultaneously using the Trypan Blue exclusion test. As a rule, more than 98% of viable cells were obtained in each isolation. The experiment was repeated with five different joint culture cells.
Chondrocyte culture and treatments
Chondrocytes were cultured in Petri dishes (60 mm in diameter) or in six-well culture wells under confluence conditions at a density of 0.5x10 6 cells/cm 2 . Chondrocytes were cultured for a mean period of 21 days in DMEM culture medium supplemented with 10% FBS, 60 U/mL penicillin, 60 μg/mL streptomycin and 2 mmol/L glutamine in humidified atmosphere, at 37 °C and 5% CO2. After an average period of 21 days, when the cells had reached a confluence of approximately 90%, they were transferred to the cell culture dishes.
After reaching confluence around 90%, after a period of three days average, the treatment of the cells started. For this purpose, cell cultures were distributed in four groups (G): G1: control chondrocytes without any treatment; G2: chondrocytes + PRP (500.000 platelets/well); G3: chondrocytes + triamcinolone (0.06 mg/mL); G4: chondrocytes + pentosan sodium polysulfate (4 mg/ mL). Volume and doses used in each treatment were adjusted according to what is recommended for the treatment of animals presenting joint lesions in the routine clinic cases (CARON, 2005) .
Preparation of PRP
Platelet Rich Plasma (PRP) was produced from blood collected from the jugular vein of healthy horses, with a collection bag containing CPDA-1 as anticoagulant. After the centrifugation protocol, which consisted of two steps, the first centrifugation was with a force of 400 x g for ten minutes, for the separation of the plasma, which was immediately transferred to two new Falcon tubes and centrifuged again with 800 x g strength for 10 minutes to form the platelet pellet. The supernatant was discarded, leaving 10 mL of PRP. PEREIRA et al. (2013) previously established this protocol in our laboratory. The pellet was resuspended and homogenized with a fraction of the supernatant plasma. A PRP sample and a whole blood sample were sent for laboratory analysis, for platelet counting and confirmation of PRP concentration prior to use of the product in the cell culture.
Oxidative profile
Oxidative damage was evaluated in cultured chondrocytes after cells were detached from the bottom of the wells with the aid of trypsin. Then, the trypsin was rinsed off and the DMEM medium added to the wells of the culture dish. Chondrocytes and DMEM medium after being removed from the culture dish were placed in Eppendorf tubes and stored at -80 °C for later processing.
Lipid peroxidation in cell culture was determined according to OHKAWA et al. (1979) , after incubation of the sample at 95 ºC in water bath, with subsequent cooling the sample to stop the reaction. Reading was performed by spectrophotometry at 495 nm. The amount of thiobarbituric acid reactive substances (TBA-RS) was expressed in nmol of malondialdehyde (MDA)/g tissue.
Activity of catalase (CAT) in cell culture was determined by the method of NELSON & KIESOW (1972) , by the addition of hydrogen peroxide to the samples and peroxide degradation analysis by spectrophotometry. Activity was expressed as U/mg protein.
Glutathione peroxidase (GPx) catalyzes the reaction of hydroperoxides with reduced glutathione; its activity was measured in a spectrophotometer at 340 nm, as already described in the literature (FLOHE, GUNZLER, 1984) .
Trypan blue
The viability test was carried out by the Trypan Blue method, with the same volumes of the culture suspension and Trypan blue dye placed in an Eppendorf tube. The sample was then homogenized and placed in a Neubauer chamber for cell counting and differentiation of living and dead cells. Cell mortality was verified by color change, with the penetration of blue dye into the cell cytoplasm (LOUIS & SIEGEL, 2011) .
MTT assay
MTT assay can measure the level of reductase in mitochondria which reflects the level of cell metabolic activity. In this assay, the activity of NAD (P) H-dependent cellular oxidoreductase Palma et al. represents the total number of viable cells. This enzyme reduces the MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide into formazan (insoluble). After the treatments, cells were collected from the culture plates and 100 μl of suspended cells were added to each well of a 96-well plate, and added 10 μl of sterilized MTT solution (5 mg/ml). After a 3h-incubation period, 100 μl of solubilization solution containing 10% SDS and 0.1% HCl was added to each well. 12 hours later, the optical density was measured at 595 nm using a plate reader.
Statistical analysis
Two-way ANOVA was used for the statistical analysis of the values obtained, followed by Duncan's multiple comparisons test. Results were considered significant when p<0.05 and expressed as mean ± standard deviation.
RESULTS AND DISCUSSION
In this study, the use of pentosan, triamcinolone and PRP in healthy chondrocytes did not alter the antioxidant status when compared to control groups. No statistical differences were observed between the groups studied when lipid peroxidation was evaluated and neither was the activity of catalase and glutathione peroxidase indicating that they could be considered safe in healthy articular conditions ( Figure 1A-C) .
When the imbalance between oxidants and antioxidants is large enough to induce cellular and/ or tissue structural and/or functional changes, the situation is called ''oxidative stress'' and is considered as an abnormal catabolic event (HENROTIN et al., 2005) . It is important to note that drugs used in the treatment of osteoarthritis should not be associated with cell damage or a stimulus that causes oxidative damage or changes in the activity of the antioxidant enzymes present in the joint.
The underlying mechanism of cartilage matrix degradation in OA is poorly understood but the ROS are implicated as the main causative factors. These ROS are capable of oxidizing and, subsequently, damaging numerous components of the joint, including collagen, proteoglycans and hyaluronan (OSTALOWSKA et al., 2006) .
Fortunately, several lines of anti-oxidant defense exist both intra-and extracellular to protect the knee joint against damage from ROS and other oxidants. Scavengers and detoxifying reactions, catalyzed meanly by anti-oxidant enzymes catalase (CAT), and glutathione transformation enzymes, including glutathione peroxidase (GPx) provide defense against ROS. In synovial fluid, these antioxidant enzymes often coexist (OSTALOWSKA et al., 2007; ALPASLAN et al., 2000) .
Lipid peroxidation and disruption of lysosomal integrity are also implicated in the pathogenesis of inflammatory processes. Lipid radicals increase edema and produce prostaglandins and various endoperoxides by increasing vascular permeability, inflammation, and chemotaxis. An increased lipid peroxidation in rheumatoid arthritis and increased levels of thiobarbituric acid-reactive material in the synovial fluid were reported in previous studies (ALPASLAN et al., 2000) . OSTALOWSKA et al. (2006) observed that all patients with OA significantly increased antioxidant enzymes activities (CAT, GPx) and MDA concentration in synovial fluid, and decreased synovial fluid viscosity when compared to the control subjects. GRIGOLO et al. (2003) reported that chondrocytes, from OA knees, activated in vitro produced ROS and significantly accelerated lipid peroxidation compared to those activated in vivo. In other study, OSTALOWSKA et al. (2006) did not observe a high concentration of MDA, which indicates lipid peroxidation, in the synovial fluid from patients with OA. In our study, we did not observe a significant difference in oxidative profile in culture of chondrocytes. We did not expect to find any changes since the cells had been removed from healthy animals. The high cell viability reported in the cultures (approximately 98%) corroborates the low activity of the antioxidant enzymes analyzed as well as the lipid peroxidation.
Frequent use of corticosteroids for joint diseases is of concern regarding the potential toxicity to articular cartilage. The TA, a commonly used intraarticular corticosteroid, is clinically non deleterious. Many studies describe that glucocorticoids can reduce cartilage integrity and chondrocyte cells viability. WILLIAMS & BRANDT (1985) demonstrated that when TA was injected into knee of guinea pigs with OA, there was a reduction in femoral condylar cartilage fibrillation, osteophytes were much less prominent and cell loss was less extensive when compared to non-treated joints. PELLETIER et al. (1995) showed a protective effect of corticosteroid injections on OA cartilage lesions under prophylactic and therapeutic conditions. Effect of TA may be mediated through a direct reduction in the expression and synthesis of proteolytic enzymes.
In our study, chondrocytes from animals with osteoarthritis were not used so that there was no interference from altered cell biology in the analysis of oxidative stress, since the objective of the study was to test the substances. Thus, possibly this was the reason we did not observe significant differences in relation to the oxidative profile of the cells treated with TA. However, an important finding was that the drug itself was not able to cause damage to the cultured cells. A novel therapeutic option to animals with OA is treatment with PRP using intra-articular injections. Studies evidenced that PRP can be considered safe to joints, and because of its antiinflammatory effects. Those are partially attributable to reduced nuclear factor (NFκB) signaling. Precise nature of the connection between PRP signaling and downstream NFκB pathway molecules is not fully established, but the underlying mechanisms are becoming increasingly understood (ANDIA & MAFFULLI, 2013) .
In 2014, TOHIDNEZHAD et al. studied the effects of PRP in primary human osteoblast cells. They demonstrated that PRP not only leads to increase the endogenous vascular endothelial growth factor, but also it may be involved in preventing oxidative damage through the nuclear erythroid 2-related factor-antioxidant response element signaling. There is a lack of controlled clinical studies proving a clinical beneficial effect of PRP, but with this study, we added more data supporting the use of concentrated platelets. As no change in antioxidant enzyme activity and lipid damage profile were observed in PRP-treated chondrocytes, their use was considered safe for chondrocytes.
Regarding to PPS use to treat OA, there is a lack of studies evaluating the effects of this drug in OA chondrocytes. In our study, it was not evident any detrimental effect with PPS administration in cell cultures. There was no evidence of a higher antioxidant defense when compared to control nontreated group.
CONCLUSION
In this study, those three treatment options were not harmful to the chondrocytes in vitro, allowing high cellular viabilities and low antioxidant activity.
